

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.02588511 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.02588511 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.92990618 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.92990618 |
| 5 | kynurenine metabolic process (GO:0070189) | 4.64047761 |
| 6 | lysine catabolic process (GO:0006554) | 4.53838785 |
| 7 | lysine metabolic process (GO:0006553) | 4.53838785 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.52940052 |
| 9 | cysteine metabolic process (GO:0006534) | 4.33983519 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.19796313 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 4.19796313 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 4.19796313 |
| 13 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.19358210 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.16380295 |
| 15 | urea metabolic process (GO:0019627) | 4.08679070 |
| 16 | urea cycle (GO:0000050) | 4.08679070 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.06629225 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.01917350 |
| 19 | glyoxylate metabolic process (GO:0046487) | 3.99586874 |
| 20 | homocysteine metabolic process (GO:0050667) | 3.92540610 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87766646 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87189458 |
| 23 | tryptophan metabolic process (GO:0006568) | 3.86954439 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.84741883 |
| 25 | glutamate metabolic process (GO:0006536) | 3.79234019 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77456166 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 3.71187462 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 3.70272755 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 3.69922937 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66717300 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 3.65815662 |
| 32 | regulation of cholesterol homeostasis (GO:2000188) | 3.65070967 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.64649431 |
| 34 | regulation of complement activation (GO:0030449) | 3.63023879 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 3.54225810 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 3.53348010 |
| 37 | cellular modified amino acid catabolic process (GO:0042219) | 3.52229314 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.50977150 |
| 39 | drug catabolic process (GO:0042737) | 3.50257966 |
| 40 | bile acid metabolic process (GO:0008206) | 3.49120413 |
| 41 | protein carboxylation (GO:0018214) | 3.48628298 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.48628298 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 3.47152256 |
| 44 | carnitine transmembrane transport (GO:1902603) | 3.44558950 |
| 45 | reverse cholesterol transport (GO:0043691) | 3.40868392 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.40423435 |
| 47 | actin-myosin filament sliding (GO:0033275) | 3.40316156 |
| 48 | muscle filament sliding (GO:0030049) | 3.40316156 |
| 49 | epoxygenase P450 pathway (GO:0019373) | 3.37410134 |
| 50 | fatty acid transmembrane transport (GO:1902001) | 3.36726204 |
| 51 | carnitine shuttle (GO:0006853) | 3.33936810 |
| 52 | acetyl-CoA metabolic process (GO:0006084) | 3.33454314 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.33217439 |
| 54 | triglyceride homeostasis (GO:0070328) | 3.32429542 |
| 55 | acylglycerol homeostasis (GO:0055090) | 3.32429542 |
| 56 | cellular glucuronidation (GO:0052695) | 3.32146883 |
| 57 | regulation of bile acid biosynthetic process (GO:0070857) | 3.32088550 |
| 58 | quaternary ammonium group transport (GO:0015697) | 3.32058562 |
| 59 | ethanol oxidation (GO:0006069) | 3.30817310 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 3.30480886 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.29719416 |
| 62 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.26725495 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.24617256 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.24617256 |
| 65 | regulation of hexokinase activity (GO:1903299) | 3.23948832 |
| 66 | regulation of glucokinase activity (GO:0033131) | 3.23948832 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.21541194 |
| 68 | phospholipid efflux (GO:0033700) | 3.21537006 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.19903479 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.19903479 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19903479 |
| 72 | macroautophagy (GO:0016236) | 3.17447281 |
| 73 | exogenous drug catabolic process (GO:0042738) | 3.14570316 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.13424941 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.13344080 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.10639782 |
| 77 | coenzyme catabolic process (GO:0009109) | 3.09571785 |
| 78 | actin-mediated cell contraction (GO:0070252) | 3.07018918 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.06445843 |
| 80 | regulation of cholesterol esterification (GO:0010872) | 3.05900406 |
| 81 | ketone body metabolic process (GO:1902224) | 3.05040186 |
| 82 | drug transmembrane transport (GO:0006855) | 3.02992235 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 3.02764805 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 2.98029767 |
| 85 | flavonoid metabolic process (GO:0009812) | 2.97841875 |
| 86 | intestinal epithelial cell development (GO:0060576) | 2.97276100 |
| 87 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.96801118 |
| 88 | oxidative demethylation (GO:0070989) | 2.95667049 |
| 89 | positive regulation of glycolytic process (GO:0045821) | 2.95577820 |
| 90 | fatty acid oxidation (GO:0019395) | 2.94480952 |
| 91 | desmosome organization (GO:0002934) | 2.94137487 |
| 92 | carnitine metabolic process (GO:0009437) | 2.93798588 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.93693488 |
| 94 | cholesterol efflux (GO:0033344) | 2.91439002 |
| 95 | myofibril assembly (GO:0030239) | 2.89959049 |
| 96 | organic acid catabolic process (GO:0016054) | 2.89384226 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 2.89384226 |
| 98 | tyrosine metabolic process (GO:0006570) | 2.89130862 |
| 99 | lipid oxidation (GO:0034440) | 2.88329448 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 2.88160164 |
| 101 | sarcomere organization (GO:0045214) | 2.88027809 |
| 102 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.87778673 |
| 103 | skeletal muscle adaptation (GO:0043501) | 2.87698634 |
| 104 | uronic acid metabolic process (GO:0006063) | 2.87656087 |
| 105 | glucuronate metabolic process (GO:0019585) | 2.87656087 |
| 106 | plasma membrane repair (GO:0001778) | 2.86307680 |
| 107 | fatty acid catabolic process (GO:0009062) | 2.85137886 |
| 108 | regulation of acrosome reaction (GO:0060046) | 2.84695113 |
| 109 | axonemal dynein complex assembly (GO:0070286) | 2.84534072 |
| 110 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.82272422 |
| 111 | regulation of skeletal muscle contraction (GO:0014819) | 2.82028945 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 2.81099533 |
| 113 | omega-hydroxylase P450 pathway (GO:0097267) | 2.80812174 |
| 114 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.79998162 |
| 115 | negative regulation of lipase activity (GO:0060192) | 2.79563400 |
| 116 | skeletal muscle contraction (GO:0003009) | 2.79074161 |
| 117 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.77500712 |
| 118 | phenylpropanoid metabolic process (GO:0009698) | 2.76852490 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 2.75744783 |
| 120 | plasma lipoprotein particle clearance (GO:0034381) | 2.74801269 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.74002566 |
| 122 | indolalkylamine metabolic process (GO:0006586) | 2.72919817 |
| 123 | cell communication involved in cardiac conduction (GO:0086065) | 2.72567136 |
| 124 | carnitine transport (GO:0015879) | 2.71157278 |
| 125 | amino-acid betaine transport (GO:0015838) | 2.71157278 |
| 126 | drug metabolic process (GO:0017144) | 2.70366616 |
| 127 | glycine metabolic process (GO:0006544) | 2.69880638 |
| 128 | cilium movement (GO:0003341) | 2.66286229 |
| 129 | regulation of relaxation of muscle (GO:1901077) | 2.63386907 |
| 130 | establishment of skin barrier (GO:0061436) | 2.56103247 |
| 131 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52506361 |
| 132 | response to muscle activity (GO:0014850) | 2.52171528 |
| 133 | ethanol metabolic process (GO:0006067) | 2.51935580 |
| 134 | actomyosin structure organization (GO:0031032) | 2.49398963 |
| 135 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.48487094 |
| 136 | regulation of cell communication by electrical coupling (GO:0010649) | 2.47728726 |
| 137 | multicellular organismal water homeostasis (GO:0050891) | 2.47170945 |
| 138 | auditory receptor cell stereocilium organization (GO:0060088) | 2.46056418 |
| 139 | striated muscle atrophy (GO:0014891) | 2.45903623 |
| 140 | biotin metabolic process (GO:0006768) | 2.44376442 |
| 141 | regulation of water loss via skin (GO:0033561) | 2.44259263 |
| 142 | vitamin transmembrane transport (GO:0035461) | 2.43319112 |
| 143 | glycogen catabolic process (GO:0005980) | 2.42897292 |
| 144 | axoneme assembly (GO:0035082) | 2.41914872 |
| 145 | striated muscle contraction (GO:0006941) | 2.39247591 |
| 146 | L-methionine salvage (GO:0071267) | 2.37247858 |
| 147 | L-methionine biosynthetic process (GO:0071265) | 2.37247858 |
| 148 | amino acid salvage (GO:0043102) | 2.37247858 |
| 149 | organic cation transport (GO:0015695) | 2.36314575 |
| 150 | thyroid hormone metabolic process (GO:0042403) | 2.34599897 |
| 151 | establishment of protein localization to Golgi (GO:0072600) | 2.30853039 |
| 152 | water homeostasis (GO:0030104) | 2.29868471 |
| 153 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.29824833 |
| 154 | piRNA metabolic process (GO:0034587) | 2.28004538 |
| 155 | actin filament-based movement (GO:0030048) | 2.27462908 |
| 156 | glucan catabolic process (GO:0009251) | 2.27118961 |
| 157 | cardiac muscle cell action potential (GO:0086001) | 2.25870499 |
| 158 | regulation of fatty acid oxidation (GO:0046320) | 2.25212713 |
| 159 | primary alcohol catabolic process (GO:0034310) | 2.23716772 |
| 160 | cardiac myofibril assembly (GO:0055003) | 2.23055665 |
| 161 | epithelial cilium movement (GO:0003351) | 2.22375587 |
| 162 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.21337612 |
| 163 | cardiac conduction (GO:0061337) | 2.20375185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.64020595 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.71916120 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.12183097 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.92486918 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.29526832 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.13918826 |
| 7 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.06858959 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89650568 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.33862386 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33738582 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.27487591 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11930919 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98438478 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.97444466 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94244369 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89434258 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85984077 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80592100 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79765248 |
| 20 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.78234983 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.77469158 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77381378 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73338001 |
| 24 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.69729320 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68973511 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64457542 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63522250 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61102458 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.60390132 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57780833 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57516376 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.53528745 |
| 33 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.53226704 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53016049 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.52570225 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50652775 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50135538 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49025961 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.48702860 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45168803 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44801391 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44703604 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42331777 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42326687 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41552470 |
| 46 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41524277 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37936350 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37295189 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37284577 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37284577 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35405918 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34743517 |
| 53 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34344499 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34270281 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33058475 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30338200 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29703195 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28472284 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28191406 |
| 60 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27112392 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25285430 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24940086 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.24604000 |
| 64 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.22519464 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21644324 |
| 66 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21277312 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21263769 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21082651 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20803006 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20237174 |
| 71 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20079070 |
| 72 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18570744 |
| 73 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18485743 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17643968 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16756013 |
| 76 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16629891 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16333794 |
| 78 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13131620 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12365244 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10434273 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10190807 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10017840 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09805599 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09805599 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08599162 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08479392 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08270681 |
| 88 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07940243 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07231380 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07109808 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06874192 |
| 92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06318683 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05975906 |
| 94 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05672669 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05134387 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05040845 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04164045 |
| 98 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02807852 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02691161 |
| 100 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02603404 |
| 101 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01420368 |
| 102 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01044428 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00834019 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00341797 |
| 105 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00123002 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99994231 |
| 107 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.98729419 |
| 108 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98325795 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98253853 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97554740 |
| 111 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96721168 |
| 112 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96721168 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96692603 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96546130 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96264541 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96216740 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96162624 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95887705 |
| 119 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95715733 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95291274 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94983740 |
| 122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94479840 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92822413 |
| 124 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92744697 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90753209 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90753209 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90554058 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90253149 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90253149 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88989053 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88325354 |
| 132 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88161602 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87896757 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86868701 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86854983 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86737933 |
| 137 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86175224 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86002972 |
| 139 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85006423 |
| 140 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84620234 |
| 141 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.83560050 |
| 142 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83530582 |
| 143 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83156379 |
| 144 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.82912035 |
| 145 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82297614 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81092462 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81035731 |
| 148 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80086717 |
| 149 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79648302 |
| 150 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79535459 |
| 151 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79015159 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78670204 |
| 153 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78512781 |
| 154 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78038909 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77651940 |
| 156 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77438763 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76881582 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 0.76637966 |
| 159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73668981 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73239919 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73230273 |
| 162 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73222092 |
| 163 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.72247988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.76491196 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.63818442 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.11921248 |
| 4 | MP0005365_abnormal_bile_salt | 4.39114002 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.85282930 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.08331974 |
| 7 | MP0003252_abnormal_bile_duct | 3.00100250 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.85320820 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.75997355 |
| 10 | MP0005083_abnormal_biliary_tract | 2.53087283 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.50769498 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.31015990 |
| 13 | MP0005332_abnormal_amino_acid | 2.22914239 |
| 14 | MP0000383_abnormal_hair_follicle | 2.16621392 |
| 15 | MP0003195_calcinosis | 2.02259210 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 1.98292008 |
| 17 | MP0000751_myopathy | 1.95170499 |
| 18 | MP0009840_abnormal_foam_cell | 1.91892207 |
| 19 | MP0002796_impaired_skin_barrier | 1.89662485 |
| 20 | MP0002254_reproductive_system_inflammat | 1.85744271 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.84292954 |
| 22 | MP0003646_muscle_fatigue | 1.81088753 |
| 23 | MP0004130_abnormal_muscle_cell | 1.78250919 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.73596238 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.68989377 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.57818771 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.56630235 |
| 28 | MP0005670_abnormal_white_adipose | 1.54966086 |
| 29 | MP0000579_abnormal_nail_morphology | 1.48873988 |
| 30 | MP0000566_synostosis | 1.47556473 |
| 31 | MP0004270_analgesia | 1.45022595 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.41862490 |
| 33 | MP0000749_muscle_degeneration | 1.41098988 |
| 34 | MP0000609_abnormal_liver_physiology | 1.37962137 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.37331361 |
| 36 | MP0000747_muscle_weakness | 1.37198303 |
| 37 | MP0002269_muscular_atrophy | 1.35739603 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.35671656 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.34869317 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.34759673 |
| 41 | MP0003329_amyloid_beta_deposits | 1.25115150 |
| 42 | MP0004043_abnormal_pH_regulation | 1.22873493 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.20513272 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17360180 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.15923858 |
| 46 | MP0003868_abnormal_feces_composition | 1.15759423 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.15697700 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.13904069 |
| 49 | MP0005330_cardiomyopathy | 1.13557337 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.12696585 |
| 51 | MP0004484_altered_response_of | 1.11928363 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.09735277 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.08204037 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.06336816 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.05930852 |
| 56 | MP0003718_maternal_effect | 1.05747868 |
| 57 | MP0000604_amyloidosis | 1.03442424 |
| 58 | MP0002822_catalepsy | 1.02185526 |
| 59 | MP0003045_fibrosis | 1.01798758 |
| 60 | MP0004264_abnormal_extraembryonic_tissu | 1.01610125 |
| 61 | MP0003635_abnormal_synaptic_transmissio | 1.01489521 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.00425478 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 0.99419261 |
| 64 | MP0009643_abnormal_urine_homeostasis | 0.98981302 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.98682742 |
| 66 | MP0004858_abnormal_nervous_system | 0.98421272 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.97594227 |
| 68 | MP0001944_abnormal_pancreas_morphology | 0.96234488 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.94272785 |
| 70 | MP0005451_abnormal_body_composition | 0.94195246 |
| 71 | MP0002160_abnormal_reproductive_system | 0.93239571 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.91840158 |
| 73 | MP0010678_abnormal_skin_adnexa | 0.91833685 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.91468872 |
| 75 | MP0001661_extended_life_span | 0.90142460 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.89216379 |
| 77 | MP0005535_abnormal_body_temperature | 0.87616686 |
| 78 | MP0005395_other_phenotype | 0.86784048 |
| 79 | MP0002168_other_aberrant_phenotype | 0.85075004 |
| 80 | MP0003880_abnormal_central_pattern | 0.85032205 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.82411739 |
| 82 | MP0002063_abnormal_learning/memory/cond | 0.80242812 |
| 83 | MP0003011_delayed_dark_adaptation | 0.79778425 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.79602033 |
| 85 | MP0009745_abnormal_behavioral_response | 0.79231462 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.78996013 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.78552056 |
| 88 | MP0008874_decreased_physiological_sensi | 0.78417902 |
| 89 | MP0002106_abnormal_muscle_physiology | 0.78194290 |
| 90 | MP0009046_muscle_twitch | 0.77589410 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.76628788 |
| 92 | MP0005501_abnormal_skin_physiology | 0.75324646 |
| 93 | MP0005647_abnormal_sex_gland | 0.75182081 |
| 94 | MP0002971_abnormal_brown_adipose | 0.74648024 |
| 95 | MP0003953_abnormal_hormone_level | 0.74593128 |
| 96 | MP0000427_abnormal_hair_cycle | 0.74040620 |
| 97 | MP0005275_abnormal_skin_tensile | 0.74022818 |
| 98 | MP0005266_abnormal_metabolism | 0.73785350 |
| 99 | MP0000759_abnormal_skeletal_muscle | 0.73340242 |
| 100 | MP0003941_abnormal_skin_development | 0.73293643 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.72661117 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.72364237 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.72161379 |
| 104 | MP0001664_abnormal_digestion | 0.72021169 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.71843312 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.71792007 |
| 107 | MP0005166_decreased_susceptibility_to | 0.69592553 |
| 108 | MP0003075_altered_response_to | 0.68908363 |
| 109 | MP0001764_abnormal_homeostasis | 0.68628099 |
| 110 | MP0008872_abnormal_physiological_respon | 0.67778337 |
| 111 | MP0005187_abnormal_penis_morphology | 0.67218209 |
| 112 | MP0001756_abnormal_urination | 0.66682793 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.66237532 |
| 114 | MP0004233_abnormal_muscle_weight | 0.65920070 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.65635076 |
| 116 | MP0001440_abnormal_grooming_behavior | 0.64414059 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.64404794 |
| 118 | MP0004924_abnormal_behavior | 0.64281695 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.64281695 |
| 120 | MP0005448_abnormal_energy_balance | 0.63981941 |
| 121 | MP0003879_abnormal_hair_cell | 0.62940128 |
| 122 | MP0005369_muscle_phenotype | 0.62682420 |
| 123 | MP0002064_seizures | 0.62441851 |
| 124 | MP0006138_congestive_heart_failure | 0.61062092 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.60986118 |
| 126 | MP0004085_abnormal_heartbeat | 0.60959372 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.60619260 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.59410518 |
| 129 | MP0002735_abnormal_chemical_nociception | 0.58152502 |
| 130 | MP0005165_increased_susceptibility_to | 0.57848189 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.57670609 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.57388985 |
| 133 | MP0001984_abnormal_olfaction | 0.57284533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.05105702 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.72328252 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.42053618 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.26964977 |
| 5 | Xanthomatosis (HP:0000991) | 4.20160118 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.10834024 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.96757396 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.73431730 |
| 9 | Hyperammonemia (HP:0001987) | 3.61521176 |
| 10 | Ketosis (HP:0001946) | 3.60543538 |
| 11 | Complement deficiency (HP:0004431) | 3.51234084 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.46953372 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.45239079 |
| 14 | Hyperglycinemia (HP:0002154) | 3.42200737 |
| 15 | Hyperglycinuria (HP:0003108) | 3.41338763 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.38618889 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.33355379 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.29492298 |
| 19 | Gout (HP:0001997) | 3.27936758 |
| 20 | Hyperkalemia (HP:0002153) | 3.27741489 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 3.27541104 |
| 22 | Muscle fiber inclusion bodies (HP:0100299) | 3.22539881 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.21143732 |
| 24 | Epidermoid cyst (HP:0200040) | 3.20049328 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18699867 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.18699867 |
| 27 | Ketoacidosis (HP:0001993) | 3.18046502 |
| 28 | Myoglobinuria (HP:0002913) | 3.16558261 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.00333594 |
| 30 | Sudden death (HP:0001699) | 2.94775858 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.91718143 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.91089181 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90314340 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.89356501 |
| 35 | Fat malabsorption (HP:0002630) | 2.83953755 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.75967168 |
| 37 | Calf muscle hypertrophy (HP:0008981) | 2.73812998 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.71366653 |
| 39 | Hyperglycemia (HP:0003074) | 2.68915523 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67889651 |
| 41 | Fair hair (HP:0002286) | 2.66002553 |
| 42 | Nemaline bodies (HP:0003798) | 2.62015397 |
| 43 | Abnormal ciliary motility (HP:0012262) | 2.60158854 |
| 44 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.59739542 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.59293790 |
| 46 | Absent/shortened dynein arms (HP:0200106) | 2.57497206 |
| 47 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.57497206 |
| 48 | Decreased circulating renin level (HP:0003351) | 2.56935036 |
| 49 | Proximal tubulopathy (HP:0000114) | 2.56285181 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.55957423 |
| 51 | Abnormality of the renal cortex (HP:0011035) | 2.55954124 |
| 52 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.50170754 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48696044 |
| 54 | Cholelithiasis (HP:0001081) | 2.48437056 |
| 55 | Abnormality of the Achilles tendon (HP:0005109) | 2.47117048 |
| 56 | Neonatal onset (HP:0003623) | 2.46493423 |
| 57 | Ventricular fibrillation (HP:0001663) | 2.46017071 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.41117177 |
| 59 | Increased connective tissue (HP:0009025) | 2.39954035 |
| 60 | Metabolic acidosis (HP:0001942) | 2.39840291 |
| 61 | Skin nodule (HP:0200036) | 2.37380513 |
| 62 | Focal motor seizures (HP:0011153) | 2.37346406 |
| 63 | Heart block (HP:0012722) | 2.36931313 |
| 64 | Abnormality of complement system (HP:0005339) | 2.36776469 |
| 65 | Abnormality of methionine metabolism (HP:0010901) | 2.36009147 |
| 66 | Increased purine levels (HP:0004368) | 2.35963006 |
| 67 | Hyperuricemia (HP:0002149) | 2.35963006 |
| 68 | Large for gestational age (HP:0001520) | 2.35734641 |
| 69 | Abnormality of renin-angiotensin system (HP:0000847) | 2.35638316 |
| 70 | Abnormality of potassium homeostasis (HP:0011042) | 2.35215481 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.34724241 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.34724241 |
| 73 | Malnutrition (HP:0004395) | 2.34579105 |
| 74 | Conjugated hyperbilirubinemia (HP:0002908) | 2.33823031 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.33642956 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.32526746 |
| 77 | Difficulty running (HP:0009046) | 2.31974339 |
| 78 | Lip pit (HP:0100267) | 2.31684764 |
| 79 | Syncope (HP:0001279) | 2.30861716 |
| 80 | Abnormality of the intrinsic pathway (HP:0010989) | 2.28694221 |
| 81 | Popliteal pterygium (HP:0009756) | 2.27876335 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.26240752 |
| 83 | Cholecystitis (HP:0001082) | 2.26240752 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.25951237 |
| 85 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.25916914 |
| 86 | Generalized aminoaciduria (HP:0002909) | 2.25775989 |
| 87 | Muscle fiber splitting (HP:0003555) | 2.24780261 |
| 88 | Pancreatic cysts (HP:0001737) | 2.24681899 |
| 89 | Genetic anticipation (HP:0003743) | 2.20935699 |
| 90 | EMG: myopathic abnormalities (HP:0003458) | 2.17800939 |
| 91 | Distal arthrogryposis (HP:0005684) | 2.17344290 |
| 92 | Myopathic facies (HP:0002058) | 2.16524097 |
| 93 | Ventricular tachycardia (HP:0004756) | 2.16486644 |
| 94 | Increased circulating renin level (HP:0000848) | 2.15743238 |
| 95 | Bundle branch block (HP:0011710) | 2.15355363 |
| 96 | Rhinitis (HP:0012384) | 2.15218307 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 2.13809457 |
| 98 | Abnormality of the lower motor neuron (HP:0002366) | 2.13370929 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.13326252 |
| 100 | Rimmed vacuoles (HP:0003805) | 2.12088738 |
| 101 | Tubular atrophy (HP:0000092) | 2.11980211 |
| 102 | Rhabdomyolysis (HP:0003201) | 2.10293266 |
| 103 | Renal cortical cysts (HP:0000803) | 2.10078633 |
| 104 | Hypercholesterolemia (HP:0003124) | 2.09962235 |
| 105 | Pancreatic fibrosis (HP:0100732) | 2.08471677 |
| 106 | Joint hemorrhage (HP:0005261) | 2.08298310 |
| 107 | Muscle stiffness (HP:0003552) | 2.06931246 |
| 108 | Hypokalemia (HP:0002900) | 2.06814335 |
| 109 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06681449 |
| 110 | Ventricular arrhythmia (HP:0004308) | 2.06185905 |
| 111 | Dysmetric saccades (HP:0000641) | 2.05917276 |
| 112 | Spontaneous abortion (HP:0005268) | 2.03927228 |
| 113 | Status epilepticus (HP:0002133) | 2.03000804 |
| 114 | Achilles tendon contracture (HP:0001771) | 2.02341019 |
| 115 | Generalized hypopigmentation of hair (HP:0011358) | 2.02098443 |
| 116 | Abnormality of the calf musculature (HP:0001430) | 2.01856998 |
| 117 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.00753305 |
| 118 | Subaortic stenosis (HP:0001682) | 2.00753305 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.97845367 |
| 120 | Hydroxyprolinuria (HP:0003080) | 1.97845367 |
| 121 | Cardiovascular calcification (HP:0011915) | 1.96464153 |
| 122 | Distal lower limb muscle weakness (HP:0009053) | 1.95952077 |
| 123 | Hyperbilirubinemia (HP:0002904) | 1.95893703 |
| 124 | Palpitations (HP:0001962) | 1.95070913 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.94467633 |
| 126 | Abnormality of chloride homeostasis (HP:0011422) | 1.92835541 |
| 127 | Myokymia (HP:0002411) | 1.92160133 |
| 128 | Lethargy (HP:0001254) | 1.91477821 |
| 129 | Hyperaldosteronism (HP:0000859) | 1.91349240 |
| 130 | Difficulty climbing stairs (HP:0003551) | 1.90822743 |
| 131 | Glycosuria (HP:0003076) | 1.90320662 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 1.90320662 |
| 133 | Furrowed tongue (HP:0000221) | 1.89719520 |
| 134 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88529892 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.88529892 |
| 136 | True hermaphroditism (HP:0010459) | 1.88408229 |
| 137 | Steatorrhea (HP:0002570) | 1.88292865 |
| 138 | Myotonia (HP:0002486) | 1.87863667 |
| 139 | Hypoglycemic seizures (HP:0002173) | 1.84367182 |
| 140 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84181148 |
| 141 | Cystic liver disease (HP:0006706) | 1.83917581 |
| 142 | Chronic bronchitis (HP:0004469) | 1.83557794 |
| 143 | Vascular calcification (HP:0004934) | 1.82630587 |
| 144 | Hypomagnesemia (HP:0002917) | 1.82198142 |
| 145 | Late onset (HP:0003584) | 1.81433860 |
| 146 | Hyperphosphatemia (HP:0002905) | 1.81288453 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.80800207 |
| 148 | Hypothermia (HP:0002045) | 1.80755323 |
| 149 | Hyperventilation (HP:0002883) | 1.79682005 |
| 150 | Chronic hepatic failure (HP:0100626) | 1.76739062 |
| 151 | Progressive cerebellar ataxia (HP:0002073) | 1.75553966 |
| 152 | Amelogenesis imperfecta (HP:0000705) | 1.70915532 |
| 153 | Abnormality of the renal medulla (HP:0100957) | 1.70814175 |
| 154 | Polydipsia (HP:0001959) | 1.70006184 |
| 155 | Abnormal drinking behavior (HP:0030082) | 1.70006184 |
| 156 | Neck muscle weakness (HP:0000467) | 1.69817779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.10294862 |
| 2 | BCKDK | 2.85185759 |
| 3 | MAP2K4 | 2.65720502 |
| 4 | MAP3K9 | 2.48651258 |
| 5 | BMPR1B | 2.42329380 |
| 6 | EPHA4 | 2.36185673 |
| 7 | TTN | 2.30266699 |
| 8 | NTRK3 | 2.25146173 |
| 9 | DAPK2 | 2.14859924 |
| 10 | MET | 2.11723930 |
| 11 | TRPM7 | 2.11045916 |
| 12 | LMTK2 | 2.06102191 |
| 13 | PHKG2 | 1.96693837 |
| 14 | PHKG1 | 1.96693837 |
| 15 | KSR2 | 1.91174838 |
| 16 | NEK1 | 1.84515676 |
| 17 | STK39 | 1.84102577 |
| 18 | MAP3K2 | 1.83783672 |
| 19 | PKN2 | 1.80842832 |
| 20 | MAP3K4 | 1.80522979 |
| 21 | FER | 1.74809118 |
| 22 | FRK | 1.74554253 |
| 23 | TRIB3 | 1.72996033 |
| 24 | RIPK1 | 1.70221279 |
| 25 | PIK3CG | 1.68094430 |
| 26 | SIK1 | 1.65564767 |
| 27 | STK38 | 1.64188096 |
| 28 | LATS1 | 1.61027114 |
| 29 | ACVR1B | 1.60602958 |
| 30 | PDK3 | 1.59195268 |
| 31 | PDK4 | 1.59195268 |
| 32 | MUSK | 1.54186330 |
| 33 | LATS2 | 1.52601206 |
| 34 | GRK1 | 1.50822873 |
| 35 | EEF2K | 1.50264308 |
| 36 | FGFR4 | 1.49203124 |
| 37 | ERN1 | 1.41483136 |
| 38 | NTRK1 | 1.38181108 |
| 39 | NME1 | 1.36335793 |
| 40 | PINK1 | 1.35442532 |
| 41 | EPHA2 | 1.35292525 |
| 42 | MST1R | 1.34471558 |
| 43 | MST4 | 1.30183571 |
| 44 | PAK6 | 1.23119542 |
| 45 | BRSK2 | 1.16832185 |
| 46 | INSRR | 1.13117534 |
| 47 | ERBB4 | 1.11869160 |
| 48 | AKT3 | 1.09475213 |
| 49 | ADRBK2 | 1.06978301 |
| 50 | MINK1 | 1.06871105 |
| 51 | * MAP3K7 | 1.03893205 |
| 52 | STK38L | 1.03354314 |
| 53 | RET | 1.03159843 |
| 54 | PAK3 | 1.01619168 |
| 55 | ERBB3 | 1.01433139 |
| 56 | PDK2 | 1.01340840 |
| 57 | MAPKAPK3 | 1.01107286 |
| 58 | TAOK1 | 0.99940833 |
| 59 | CAMKK1 | 0.99459508 |
| 60 | PTK6 | 0.98941775 |
| 61 | STK3 | 0.93969623 |
| 62 | SGK3 | 0.92624265 |
| 63 | MAP3K1 | 0.92029770 |
| 64 | STK24 | 0.91861457 |
| 65 | PRKCE | 0.87036146 |
| 66 | DMPK | 0.85850797 |
| 67 | MAP2K6 | 0.85646194 |
| 68 | MAP4K2 | 0.84898986 |
| 69 | MAP2K1 | 0.84882983 |
| 70 | RPS6KB2 | 0.83327229 |
| 71 | PRKD3 | 0.82492042 |
| 72 | MAPK11 | 0.81587139 |
| 73 | CAMK1D | 0.78071177 |
| 74 | PDPK1 | 0.77903029 |
| 75 | CAMK2G | 0.77299650 |
| 76 | MAP3K3 | 0.76749475 |
| 77 | PRKCI | 0.73365996 |
| 78 | CAMK2D | 0.73048588 |
| 79 | MAP2K7 | 0.72757174 |
| 80 | PRKAA2 | 0.72353944 |
| 81 | MAPK15 | 0.72292407 |
| 82 | MAP2K3 | 0.71823104 |
| 83 | FGFR3 | 0.71479694 |
| 84 | KSR1 | 0.71071337 |
| 85 | FGFR2 | 0.70532172 |
| 86 | MAPK12 | 0.69440617 |
| 87 | PTK2 | 0.68160672 |
| 88 | TAOK3 | 0.66047363 |
| 89 | DAPK1 | 0.65987576 |
| 90 | PDK1 | 0.65961024 |
| 91 | CASK | 0.65394209 |
| 92 | PRKAA1 | 0.65130866 |
| 93 | MAPKAPK5 | 0.64766930 |
| 94 | SGK2 | 0.64680242 |
| 95 | OXSR1 | 0.64658393 |
| 96 | MAP3K12 | 0.63399577 |
| 97 | WNK4 | 0.60757176 |
| 98 | PDGFRA | 0.60051453 |
| 99 | STK11 | 0.59106718 |
| 100 | EIF2AK3 | 0.57099086 |
| 101 | MAPK13 | 0.56132438 |
| 102 | BCR | 0.55899458 |
| 103 | MAP3K5 | 0.55743292 |
| 104 | CAMK2A | 0.55721723 |
| 105 | MAP3K13 | 0.55499819 |
| 106 | TGFBR1 | 0.54775162 |
| 107 | JAK2 | 0.53511706 |
| 108 | CDK5 | 0.53322011 |
| 109 | EPHA3 | 0.53306915 |
| 110 | PIK3CA | 0.52716011 |
| 111 | TNK2 | 0.52685637 |
| 112 | PNCK | 0.52612500 |
| 113 | SGK223 | 0.52148234 |
| 114 | SGK494 | 0.52148234 |
| 115 | CAMK1 | 0.51201988 |
| 116 | SGK1 | 0.51003174 |
| 117 | PRKCG | 0.50873731 |
| 118 | GRK5 | 0.50763189 |
| 119 | NEK6 | 0.50111349 |
| 120 | NLK | 0.50098539 |
| 121 | MAP3K11 | 0.49683235 |
| 122 | RPS6KB1 | 0.48154309 |
| 123 | ERBB2 | 0.48034094 |
| 124 | FGFR1 | 0.47403009 |
| 125 | RIPK4 | 0.46741472 |
| 126 | BMX | 0.45267190 |
| 127 | CAMK4 | 0.45177072 |
| 128 | MYLK | 0.45140669 |
| 129 | PTK2B | 0.44658407 |
| 130 | ZAK | 0.44104814 |
| 131 | PRKACG | 0.43562323 |
| 132 | PRKACA | 0.42477806 |
| 133 | AKT2 | 0.42279408 |
| 134 | CAMK1G | 0.40660502 |
| 135 | WNK3 | 0.40565600 |
| 136 | PRKCZ | 0.40432045 |
| 137 | MTOR | 0.39971974 |
| 138 | PRKG1 | 0.39847989 |
| 139 | WNK1 | 0.34299866 |
| 140 | ADRBK1 | 0.33393712 |
| 141 | PBK | 0.31193184 |
| 142 | CDK19 | 0.30109089 |
| 143 | MELK | 0.29551158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.89262150 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73849298 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33469209 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04749606 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65030454 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38967017 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21061386 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20683528 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17205137 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10977748 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00357435 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99437183 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90489287 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.79389486 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78413867 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.73549916 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73259714 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.72437463 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.70903587 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63971574 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62756954 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62708929 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.57584609 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.57013060 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55163424 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54116828 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.46462506 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43284218 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40176241 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39908157 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38514836 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37537679 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33547269 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.32777846 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30451820 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29626958 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23897433 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17755829 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16215084 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14493417 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05993825 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.05629669 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04179768 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04116330 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01982831 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00938049 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00699355 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99219803 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98357851 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.97762440 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96440086 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92562785 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89855471 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86704004 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84793613 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.83129405 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81806478 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80696692 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.79753658 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79689665 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78799484 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78266473 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76299208 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73864101 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72682155 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70645875 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68625965 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68148237 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68084722 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65860811 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.65590245 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65554728 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.61893423 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61317373 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.60537050 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59985729 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59821165 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.59581850 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.59113325 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57448064 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57318555 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56619709 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.55669067 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54889868 |
| 85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53596508 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53441913 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53419858 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53190258 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53146957 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52078472 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51893098 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48897226 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48248940 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46202367 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46058857 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45759951 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45126823 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44203019 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42823541 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41649299 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41189844 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40860672 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40500313 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40061971 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.39789966 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39406215 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38872863 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38761033 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38323445 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36796438 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36380691 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35595219 |
| 113 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35488689 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35281853 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35094362 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34676874 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33983525 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33453050 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.33071682 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31818034 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27499911 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26779537 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.26697622 |

